IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 71, Issue 3, 2012, Pages 463-468

  Niewold, Timothy B ^a   Kelly, Jennifer A ^b   Kariuki, Silvia N ^a   Franek, Beverly S ^a   Kumar, Akaash A ^a   Kaufman, Kenneth M ^b   Thomas, Kenaz ^b   Walker, Daniel ^b   Kamp, Stan ^b   Frost, Jacqueline M ^c   Wong, Andrew K ^d   Merrill, Joan T ^b,e   Alarcón Riquelme, Marta E ^b,f   Tikly, Mohammed ^c   Ramsey Goldman, Rosalind ^g,h   Reveille, John D ^g,i   Petri, Michelle A ^g,j   Edberg, Jeffrey C ^g,k   Kimberly, Robert P ^g,k   Alarcón, Graciela S ^g,k   Kamen, Diane L ^l   Gilkeson, Gary S ^l   Vyse, Timothy J ^m   James, Judith A ^b,e   Gaffney, Patrick M ^b   Moser, Kathy L ^b   Crow, Mary K ⁿ   Harley, John B ^o   more..

^a UNIVERSITY OF CHICAGO   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF GRANADA   (Spain)

^g PROFILE Study Group   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ UNIVERSITY OF TEXAS   (United States)

^j JOHNS HOPKINS UNIVERSITY   (United States)

^k UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^l MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^m KING'S COLLEGE LONDON   (United Kingdom)

ⁿ HOSPITAL FOR SPECIAL SURGERY   (United States)

^o CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; DOUBLE STRANDED DNA ANTIBODY; INTERFERON REGULATORY FACTOR 5; RO ANTIBODY;

AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AFRICAN; SYSTEMIC LUPUS ERYTHEMATOSUS;

AFRICAN AMERICANS; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; CASE-CONTROL STUDIES; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERFERON REGULATORY FACTORS; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84863115400     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200463     Document Type: Article

References (34)

1. Ramos PS, Kelly JA, Gray-McGuire C, et al. Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus. Genes Immun 2006;7:417-32. (Pubitemid 44111647)
2. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33. (Pubitemid 37255038)
3. Lövgren T, Eloranta ML, Båve U, et al. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 2004;50:1861-72. (Pubitemid 38725099)
4. Koffler D, Agnello V, Carr RI, et al. Anti-DNA antibodies and renal lesions of patients with systemic lupus erythematosus. Transplant Proc 1969;1:933-8.
5. Barnes BJ, Moore PA, Pitha PM. Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J Biol Chem 2001;276:23382-90.
6. Graham RR, Kyogoku C, Sigurdsson S, et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci USA 2007;104:6758-63. (Pubitemid 47175574)
7. Blanco P, Palucka AK, Gill M, et al. Induction of dendritic cell differentiation by IFNalpha in systemic lupus erythematosus. Science 2001;294:1540-3. (Pubitemid 33063928)
8. Niewold TB, Hua J, Lehman TJ, et al. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun 2007;8:492-502. (Pubitemid 47365615)
9. Hooks JJ, Moutsopoulos HM, Geis SA, et al. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 1979;301:5-8. (Pubitemid 9226519)
10. Weckerle CE, Franek BS, Kelly JA, et al. Network analysis of associations between serum interferon-a activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis Rheum 2011;63:1044-53.
11. Kirou KA, Lee C, George S, et al. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 2005;52:1491-503. (Pubitemid 40663941)
12. Rönnblom LE, Alm GV, Oberg KE. Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour. J Intern Med 1990;227:207-10. (Pubitemid 20075945)
13. Niewold TB, Swedler WI. Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C. Clin Rheumatol 2005;24:178-81. (Pubitemid 40552976)
14. Niewold TB. Interferon Alpha as a Primary Pathogenic Factor in Human Lupus. J Interferon Cytokine Res 2011; Published Online First:16 September 2011, doi:10.1089/jir.2011.0071.
15. Salloum R, Franek BS, Kariuki SN, et al. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients. Arthritis Rheum 2010;62:553-61.
16. Niewold TB, Kelly JA, Flesch MH, et al. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum 2008;58:2481-7.
17. Kariuki SN, Kirou KA, MacDermott EJ, et al. Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo. J Immunol 2009;182:34-8.
18. Kariuki SN, Niewold TB. Genetic regulation of serum cytokines in systemic lupus erythematosus. Transl Res 2010;155:109-17.
19. Kariuki SN, Franek BS, Kumar AA, et al. Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus. Arthritis Res Ther 2010;12:R151.
20. Salloum R, Niewold TB. Interferon regulatory factors in human lupus pathogenesis. Transl Res 2011;157:326-31.
21. Alarcón GS, McGwin G Jr, Petri M, et al.; PROFILE Study Group. Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 2002;11:95-101. (Pubitemid 34259439)
22. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7. (Pubitemid 13221242)
23. Sigurdsson S, Göring HH, Kristjansdottir G, et al. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet 2008;17:872-81. (Pubitemid 351368993)
24. Hua J, Kirou K, Lee C, et al. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum 2006;54:1906-16. (Pubitemid 43877940)
25. Jabs WJ, Hennig C, Zawatzky R, et al. Failure to detect antiviral activity in serum and plasma of healthy individuals displaying high activity in ELISA for IFN-alpha and IFN-beta. J Interferon Cytokine Res 1999;19:463-9. (Pubitemid 29269936)
26. Niewold TB, Rivera TL, Buyon JP, et al. Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus. Arthritis Rheum 2008;58:541-6. (Pubitemid 351294888)
27. Niewold TB, Kariuki SN, Morgan GA, et al. Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy. Arthritis Rheum 2009;60:1815-24.
28. Kelly JA, Kelley JM, Kaufman KM, et al. Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun 2008;9:187-94. (Pubitemid 351584185)
29. Richez C, Yasuda K, Bonegio RG, et al. IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus. J Immunol 2010;184:796-806.
30. Ding C, Cai Y, Marroquin J, et al. Plasmacytoid dendritic cells regulate autoreactive B cell activation via soluble factors and in a cell-to-cell contact manner. J Immunol 2009;183:7140-9.
31. Brummel R, Roberts TL, Stacey KJ, et al. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice. Eur J Immunol 2006;36:1951-62. (Pubitemid 44089060)
32. Taylor KE, Remmers EF, Lee AT, et al. Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus. PLoS Genet 2008;4:e1000084.
33. Robinson T, Kariuki SN, Franek BS, et al. Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-a and serologic autoimmunity in lupus patients. J Immunol 2011;187:1298-303.
34. Kokkonen H, Johansson M, Innala L, et al. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. Arthritis Res Ther 2007;9:R56.